Factors driving the growth of this market include high incidence and large economic burden of autoimmune diseases, increasing healthcare expenditure, and growing access to medical insurance in the US.
According to a new market research "Autoimmune Disease Diagnosis Market by Products (Consumables, Assay Kits, Instruments, Services), Test Type (Inflammatory Markers, Autoantibodies), Disease (RA, SLE, Thyroiditis, Scleroderma), End Users (Hospitals, Clinical Labs) - Global Forecast to 2022", published by MarketsandMarkets™, the market is expected to reach USD 4.73 Billion by 2022 from USD 3.09 Billion in 2017, at a CAGR of 8.9%.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174826519
Key players in the Autoimmune Disease Diagnosis Market include Thermo Fisher Scientific. (US), Danaher (US), HYCOR Biomedical (US), Siemens (Germany), Bio-Rad Laboratories. (US), and Abbott (US).
Consumables and assay kits are estimated to account for the largest share of the market in 2017
By product and service, the Autoimmune Disease Diagnosis Market is classified into consumables & assay kits, instruments and services. The consumables & assay kits segment is expected to lead the global autoimmune disease diagnosis in 2017. Factors driving the growth of this segment include increasing adoption of consumables in hospitals and clinical laboratories, rising incidence of autoimmune diseases, and increasing demand for quick results.
Browse and in-depth TOC on " Autoimmune Disease Diagnosis Market "
64 – Tables
36 - Figures
121 – Pages
Routine laboratory tests are estimated to command the largest share of the market during the forecast period
On the basis of test type, the Autoimmune Disease Diagnosis Market is categorized into routine laboratory tests, inflammatory markers, autoantibodies and immunologic tests, and other tests. In 2017, the routine laboratory tests segment is estimated to account for the largest share of the global Autoimmune Disease Diagnosis Market. The increasing incidence autoimmune diseases, along with increasing adoption of routine laboratory tests for a variety of diseases are the key factors driving the growth of this end-user segment.
The rheumatoid arthritis segment is expected to dominate the market in 2017
By disease, the market is segmented into systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome, thyroiditis, scleroderma, and other diseases. The rheumatoid disease segment is expected to account for the largest share of the global autoimmune disease diagnosis in 2017. The growth of this segment is mainly driven by the increasing incidences of the disease.
Clinical laboratories are estimated to command the largest share of the market during the forecast period
On the basis of end user, the Autoimmune Disease Diagnosis Market is categorized into clinical laboratories, hospitals, and other end users. The clinical laboratories segment is estimated to account for the largest share of the global Autoimmune Disease Diagnosis Market during the forecast period. The heavy burden of autoimmune diseases, along with the accessibility and availability of diagnosis and treatment instruments in clinical laboratories in a short period of time are the key factors driving the growth of this end-user segment.
North America is estimated to command the largest share of the market
Based on region, the Autoimmune Disease Diagnosis Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to dominate the Autoimmune Disease Diagnosis Market in 2017. This is attributed to factors such as accessibility to advanced technologies and opportunities for advanced autoimmune diagnostic testing and screening, growing incidence of autoimmune diseases, and technological advancements of autoimmune disease diagnosis in the region as compared to other regions.
Request FREE Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=174826519
Autoimmune Disease Diagnosis Market – Trends Estimates High Demand by 2022
This report aims to provide detailed insights into the global fluid management system market.
It provides valuable information on the type, procedure, application, and region in the market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153551158 Key Factors Driving Market Growth: The Growth in this fluid management market is driven by the increasing number of minimally invasive surgeries, increasing ESRD patient base, technological advancements in fluid management systems, and an increase in government funds and grants worldwide for endosurgical procedures, rising number of hospitals, and investments in endoscopy and laparoscopy facilities are driving the market.
The untapped potential in emerging markets and the rising use of single-use disposable devices and accessories are also expected to offer growth opportunities for players operating in the fluid management systems and accessories market.
Standalone fluid management systems are less expensive than integrated systems.
This is a major factor contributing to the high adoption of these products in hospitals, especially in developing countries.
Read about Few things to know about India's Healthcare System and five essential things you should know about India's healthcare system.
The global Parkinsons disease treatment market is expected to reach USD 5.69 billion by 2022 from USD 4.24 billion in 2017, at a CAGR of 6.1%.
In the severe stages, medications do not show pharmacological action in relieving disease symptoms.
Neurologists perform thalamotomy, pallidotomy, or implant deep brain stimulation (DBS) devices in order to ease symptoms.Moreover, the focus on gene therapy research has increased.
According to the Parkinson’s Disease Clinic and Research Center, University of California, US, gene therapy for Parkinson’s disease has shown promising results in phase I studies.
Surgical treatments, restriction on the use of medications in severe stages of the disease, and the increased focus on gene therapy research are expected to restrain the demand for therapeutic drugs used in Parkinson’s disease.Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=47265247The Parkinson’s disease treatment market is segmented on the basis of drug class, distribution channel, patient care setting, and region.
On the basis of drug class, the market is segmented into carbidopa/levodopa, dopamine receptor agonists, MAO-inhibitors, COMT-inhibitors, anticholinergics and other drugs.
Enteric contamination is a kind of intestinal disorder that reasons signs and symptoms starting from moderate gastroenteritis to systemic infections and intense diarrhea.
According to WHO in 2017, Infectious gastroenteritis bills for 1 billion instances of diarrhea globally and over 2 million deaths annually.
In addition to this, in keeping with Bill and Melinda Gates Foundation, 2017, enteric and diarrheal illnesses results in the death of approximately 500,000 youngsters, beneath neath the age of 5 every year, and youngsters who continue to exist repeated infections with the aid of using intestine pathogens withinside the early years in their existence might also additionally be afflicted by lifelong fitness problems.
This non-stop upward push in enteric infections amongst youngsters is one of the principal elements contributing to the increase of the enteric disease testing market.
Continuous release of enteric disorder trying out merchandise with the aid of using key producers is anticipated to boost up the increase of the market over the forecast period.
For instance, in July 2014, Trinity Biotech percent obtained CE marking for its new Uni-Gold H. pylori Antigen point-of-care test.
In a recent business intelligence study, Fact.MR presents the nitty-gritty of the global medical marker bands market considering 2014-2018 as the historic year and 2019–2029 as the stipulated timeframe.
Further, all the market shares associated with the market as well as the segments are expressed in terms of value and volume.You can Request an Example Copy from here - https://www.factmr.com/connectus/sample?flag=S_id=4364Developing economies are highly dependent on developed nations like US and Europe for availing advanced manufacturing facilities.
Developing regions like Asia Pacific import medical marker bands from developed regions.
Cheap materials have emerged in the market as the conventional ones like gold and platinum are costly.
Different manufacturers including Putnam Plastics Corp. who have been using materials like polymers and Stanford advanced materials to manufacture medical marker bands, are now switching towards different materials that are cost-effective.
Both materials, tantalum and polymer are gaining popularity and market penetration in regions like Asia Pacific and MEA as they are affordable.Attempt here to buy this Report from here – https://www.factmr.com/checkout/4364/SApproaches that are catheter-based and are minimally-invasive are getting adopted in medical treatments like Heart surgeries because of the different benefits offered by them like reduced morbidity, less recovery time and improved outcomes.
For sure, after gaining your access to a medical dispensary in Bakersfield using your card, you consider is to avail your very first medical marijuana product right away. But before you bring home your medical-grade cannabis product, do you wonder why medical marijuana becomes an effective option to relieve some specific ailments? Well, probably because they are naturally made to be medicine for certain diseases? Or its medical possibilities are generated from each component that serves their respective functions inside the human body. Perhaps it is.
To give you a more precise and comprehensive idea regarding medical marijuana, you can read the discussion below to learn more about it. Let’s see.
Growth in this market is mainly driven by the increasing incidence and prevalence of cardiovascular disease, government initiatives in China, and the increasing number of hospitals.The China cardiology information system market is projected to reach $54 million by 2024 from $35 million in 2019, at a CAGR of 8.9% during the forecast period.
Growth in this market is mainly driven by the increasing incidence and prevalence of cardiovascular disease, government initiatives in China, and the increasing number of hospitals.Get Sample PDF Copy at https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=264168583Key Benefits -> Rising incidence of cardiovascular disease in China> Government initiatives for HCIT development> Increasing number of hospitals in ChinaThe key players considered in the report are the following:.
Esaote (Italy)This Research Report Examines:> The integrated systems segment is expected to grow at the highest CAGR during the forecast period> The software segment accounted for the largest share of the China cardiology information system market in 2018> L3A hospitals accounted for the largest share of the China cardiology information system market in 2018The China cardiology information system market is projected to reach $54 million by 2024 from $35 million in 2019, at a CAGR of 8.9% during the forecast period.
Growth in this market is mainly driven by the increasing incidence and prevalence of cardiovascular disease, government initiatives in China, and the increasing number of hospitals.Read More: https://www.marketsandmarkets.com/PressReleases/cardiology-information-system.asp
This report aims to provide detailed insights into the global fluid management system market.
It provides valuable information on the type, procedure, application, and region in the market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153551158 Key Factors Driving Market Growth: The Growth in this fluid management market is driven by the increasing number of minimally invasive surgeries, increasing ESRD patient base, technological advancements in fluid management systems, and an increase in government funds and grants worldwide for endosurgical procedures, rising number of hospitals, and investments in endoscopy and laparoscopy facilities are driving the market.
The untapped potential in emerging markets and the rising use of single-use disposable devices and accessories are also expected to offer growth opportunities for players operating in the fluid management systems and accessories market.
Standalone fluid management systems are less expensive than integrated systems.
This is a major factor contributing to the high adoption of these products in hospitals, especially in developing countries.
In a recent business intelligence study, Fact.MR presents the nitty-gritty of the global medical marker bands market considering 2014-2018 as the historic year and 2019–2029 as the stipulated timeframe.
Further, all the market shares associated with the market as well as the segments are expressed in terms of value and volume.You can Request an Example Copy from here - https://www.factmr.com/connectus/sample?flag=S_id=4364Developing economies are highly dependent on developed nations like US and Europe for availing advanced manufacturing facilities.
Developing regions like Asia Pacific import medical marker bands from developed regions.
Cheap materials have emerged in the market as the conventional ones like gold and platinum are costly.
Different manufacturers including Putnam Plastics Corp. who have been using materials like polymers and Stanford advanced materials to manufacture medical marker bands, are now switching towards different materials that are cost-effective.
Both materials, tantalum and polymer are gaining popularity and market penetration in regions like Asia Pacific and MEA as they are affordable.Attempt here to buy this Report from here – https://www.factmr.com/checkout/4364/SApproaches that are catheter-based and are minimally-invasive are getting adopted in medical treatments like Heart surgeries because of the different benefits offered by them like reduced morbidity, less recovery time and improved outcomes.
Read about Few things to know about India's Healthcare System and five essential things you should know about India's healthcare system.
For sure, after gaining your access to a medical dispensary in Bakersfield using your card, you consider is to avail your very first medical marijuana product right away. But before you bring home your medical-grade cannabis product, do you wonder why medical marijuana becomes an effective option to relieve some specific ailments? Well, probably because they are naturally made to be medicine for certain diseases? Or its medical possibilities are generated from each component that serves their respective functions inside the human body. Perhaps it is.
To give you a more precise and comprehensive idea regarding medical marijuana, you can read the discussion below to learn more about it. Let’s see.
The global Parkinsons disease treatment market is expected to reach USD 5.69 billion by 2022 from USD 4.24 billion in 2017, at a CAGR of 6.1%.
In the severe stages, medications do not show pharmacological action in relieving disease symptoms.
Neurologists perform thalamotomy, pallidotomy, or implant deep brain stimulation (DBS) devices in order to ease symptoms.Moreover, the focus on gene therapy research has increased.
According to the Parkinson’s Disease Clinic and Research Center, University of California, US, gene therapy for Parkinson’s disease has shown promising results in phase I studies.
Surgical treatments, restriction on the use of medications in severe stages of the disease, and the increased focus on gene therapy research are expected to restrain the demand for therapeutic drugs used in Parkinson’s disease.Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=47265247The Parkinson’s disease treatment market is segmented on the basis of drug class, distribution channel, patient care setting, and region.
On the basis of drug class, the market is segmented into carbidopa/levodopa, dopamine receptor agonists, MAO-inhibitors, COMT-inhibitors, anticholinergics and other drugs.
Growth in this market is mainly driven by the increasing incidence and prevalence of cardiovascular disease, government initiatives in China, and the increasing number of hospitals.The China cardiology information system market is projected to reach $54 million by 2024 from $35 million in 2019, at a CAGR of 8.9% during the forecast period.
Growth in this market is mainly driven by the increasing incidence and prevalence of cardiovascular disease, government initiatives in China, and the increasing number of hospitals.Get Sample PDF Copy at https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=264168583Key Benefits -> Rising incidence of cardiovascular disease in China> Government initiatives for HCIT development> Increasing number of hospitals in ChinaThe key players considered in the report are the following:.
Esaote (Italy)This Research Report Examines:> The integrated systems segment is expected to grow at the highest CAGR during the forecast period> The software segment accounted for the largest share of the China cardiology information system market in 2018> L3A hospitals accounted for the largest share of the China cardiology information system market in 2018The China cardiology information system market is projected to reach $54 million by 2024 from $35 million in 2019, at a CAGR of 8.9% during the forecast period.
Growth in this market is mainly driven by the increasing incidence and prevalence of cardiovascular disease, government initiatives in China, and the increasing number of hospitals.Read More: https://www.marketsandmarkets.com/PressReleases/cardiology-information-system.asp
Enteric contamination is a kind of intestinal disorder that reasons signs and symptoms starting from moderate gastroenteritis to systemic infections and intense diarrhea.
According to WHO in 2017, Infectious gastroenteritis bills for 1 billion instances of diarrhea globally and over 2 million deaths annually.
In addition to this, in keeping with Bill and Melinda Gates Foundation, 2017, enteric and diarrheal illnesses results in the death of approximately 500,000 youngsters, beneath neath the age of 5 every year, and youngsters who continue to exist repeated infections with the aid of using intestine pathogens withinside the early years in their existence might also additionally be afflicted by lifelong fitness problems.
This non-stop upward push in enteric infections amongst youngsters is one of the principal elements contributing to the increase of the enteric disease testing market.
Continuous release of enteric disorder trying out merchandise with the aid of using key producers is anticipated to boost up the increase of the market over the forecast period.
For instance, in July 2014, Trinity Biotech percent obtained CE marking for its new Uni-Gold H. pylori Antigen point-of-care test.